Key Metrics
CiteScore 

9
Eigenfactor 

0.01 - 0.05
Impact Factor 

5 - 10
Scite Index 

0.89 5-Year SI

SJR 

Q1Neurology

SNIP 

1
Recommended pre-submission checks
Powered by 

Topics Covered on Alzheimer's Research and Therapy
Alzheimer's Research and Therapy Journal Specifications
Indexed in the following public directories
Web of Science
Scopus
DOAJ
SJR
| Overview | |
| Publisher | Springer Nature |
| Language | English |
| Frequency | Continuous publication |
| Article Processing Charges | GBP 2390 | USD 3590 |
| Publication Time | 16 |
| Editorial Review Process | Peer review |
| General Details | |
| Language | English |
| Society/Institute/Sponsor | Alzheimer's Disease International |
| Frequency | Continuous publication |
| Publication Start Year | 2009 |
| Publisher URL | Visit website |
| Website URL | Visit website |
| Publication Details | |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY, CC0 |
| OA statement | Visit website |
View less
Planning to publish in Alzheimer's Research and Therapy ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in Alzheimer's Research and Therapy
Metabolic parameter variability, brain structure, perfusion, and cognition: a population-based study.
- 20 May 2026
- Alzheimer's research & therapy
Safety, tolerability and immunogenicity of vaccine ALZ-101 in patients with early Alzheimer's disease: randomised, controlled trial.
- 19 May 2026
- Alzheimer's research & therapy
Clarifying comparative claims in digital cognitive assessment: a matters arising on multimodal detection of cognitive impairment and amyloid positivity.
- 19 May 2026
- Alzheimer's research & therapy
Re: Clarifying comparative claims in digital cognitive assessment: Assessing concurrent validity in a shared cohort.
- 19 May 2026
- Alzheimer's research & therapy
TNF inhibition differentially impacts regional Abeta immunotherapy efficacy in the humanized hAbSAA mouse model.
- 19 May 2026
- Alzheimer's research & therapy
Willingness and barriers to blood-based biomarker testing of Alzheimer's disease in the general population in the Czech Republic.
- 18 May 2026
- Alzheimer's research & therapy
Metabolic parameter variability, brain structure, perfusion, and cognition: a population-based study.
- 20 May 2026
- Alzheimer's research & therapy
Safety, tolerability and immunogenicity of vaccine ALZ-101 in patients with early Alzheimer's disease: randomised, controlled trial.
- 19 May 2026
- Alzheimer's research & therapy
Clarifying comparative claims in digital cognitive assessment: a matters arising on multimodal detection of cognitive impairment and amyloid positivity.
- 19 May 2026
- Alzheimer's research & therapy
Re: Clarifying comparative claims in digital cognitive assessment: Assessing concurrent validity in a shared cohort.
- 19 May 2026
- Alzheimer's research & therapy
TNF inhibition differentially impacts regional Abeta immunotherapy efficacy in the humanized hAbSAA mouse model.
- 19 May 2026
- Alzheimer's research & therapy
Willingness and barriers to blood-based biomarker testing of Alzheimer's disease in the general population in the Czech Republic.
- 18 May 2026
- Alzheimer's research & therapy